Submitted by: Submitted by jayram
Views: 10
Words: 453
Pages: 2
Category: Business and Industry
Date Submitted: 03/01/2016 06:24 AM
RnRMarketResearch.com includes Global Rheumatoid Arthritis Drugs Market 2016-2020 a new research reports in its store. The analysts forecast global Rheumatoid Arthritis (RA) drugs market to grow at a CAGR of 3.43% during the period 2016-2020.
RA is a chronic inflammatory autoimmune disease seen in people aged between 30 and 60 years. The symptoms of the disease appear slowly, with mild pain around the joints coupled with stiffness and fatigue. In the later stages, it causes inflammation of the joints. Genetic and environmental elements are known to contribute to the development of the condition. DMARDs, NSAIDs, corticosteroids, and analgesics are being developed and administered to treat individuals with RA.
The report covers the present scenario and the growth prospects of the global RA drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat the disease.
Inquire on the Report http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=494943
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
The report, Global Rheumatoid Arthritis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.
Purchase a Copy of the Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=494943 (Single User License - US $3000)
Key vendors –AbbVie, Amgen, Bristol-Myers Squibb (BMS), Johnson & Johnson, Pfizer, F. Hoffmann-La Roche
Other prominent vendors – Ablynx, Alder BioPharmaceuticals, Antares Medical Services, Astellas Pharma, AstraZeneca, Boehringer Ingelheim, Can-Fite BioPharma, Celgene, Celltrion, ChemoCentryx, Eisai, Eli Lilly, Gilead Sciences, GlaxoSmithKline, Incyte, KaloBios...